In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

US stocks rose on Friday, notching weekly wins across the major averages after an easing in US-China trade tensions.

Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.

NBC News and MSNBC medical contributor Dr. Kavita Patel joins ‘Fast Money’ to discuss Novo Nordisk after the company ousted ...

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock ...

Health-care companies rose sharply, recouping some losses from earlier in the week. UnitedHealth Group recouped 6% on Friday, but still lost almost one quarter of its value for the week after the ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is being ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...